Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A Review

References

• Couri T, Pillai A. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019;13(2):125–137.
   PubMed Web of Science ®Google Scholar
• Deng M, Sun S, Zhao R, et al. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. Mol Med. 2022;28(1):16.
   PubMed Web of Science ®Google Scholar
• Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188314.
   PubMed Web of Science ®Google Scholar
• Su K, Guo L, Ma W, et al. PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: a propensity score matching study. Front Immunol. 2022;13:972503.
   PubMed Web of Science ®Google Scholar
• Su K, Gu T, Xu K, et al. Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study. Hepatol Int. 2022;16(4):858–867.
   PubMed Web of Science ®Google Scholar
• Cheng AL, Hsu C, Chan SL, et al. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol. 2020;72(2):307–319.
   PubMed Web of Science ®Google Scholar
• Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223–238.
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370.
   PubMed Web of Science ®Google Scholar
• Su K, Huang W, Li X, et al. Evaluation of lactate dehydrogenase and alkaline phosphatase as predictive biomarkers in the prognosis of hepatocellular carcinoma and development of a new nomogram. J Hepatocell Carcinoma. 2023;10:69–79.
   PubMed Web of Science ®Google Scholar
• Su K, Guo L, He K, et al. PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma. Front Oncol. 2022;12:873830.
   PubMed Web of Science ®Google Scholar
• Su K, Liu Y, Wang P, et al. Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study. Hepatol Int. 2022;16(5):1208–1219.
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–180.
   PubMed Web of Science ®Google Scholar
• Kawai K, Sunami E, Yamaguchi H, et al. Nomograms for colorectal cancer: a systematic review. World J Gastroenterol. 2015;21(41):11877–11886.
   PubMed Web of Science ®Google Scholar
• Petruzziello A. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma. Open Virol J. 2018;12:26–32.
   PubMedGoogle Scholar
• Xie Y. Hepatitis B virus-associated hepatocellular carcinoma. Adv Exp Med Biol. 2017;1018:11–21.
   PubMed Web of Science ®Google Scholar
• Khatun M, Ray R, Ray RB. Hepatitis C virus associated hepatocellular carcinoma. Adv Cancer Res. 2021;149:103–142.
   PubMed Web of Science ®Google Scholar
• Tang B, Zhu J, Li J, et al. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun Signal. 2020;18(1):174.
   PubMed Web of Science ®Google Scholar
• Li W, Han J, Yuan K, et al. Integrated tumor stromal features of hepatocellular carcinoma reveals two distinct subtypes with prognostic/predictive significance. Aging. 2019;11(13):4478–4509.
   PubMedGoogle Scholar
• Liu GM, Zeng HD, Zhang CY, et al. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int. 2019;19:138.
   PubMed Web of Science ®Google Scholar
• Longato E, Vettoretti M, Di Camillo B. A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models. J Biomed Inform. 2020;108:103496.
   PubMed Web of Science ®Google Scholar
• Razdan S, Sljivich M, Pfail J, et al. Predicting morbidity and mortality after radical cystectomy using risk calculators: a comprehensive review of the literature. Urol Oncol. 2021;39(2):109–120.
   PubMed Web of Science ®Google Scholar
• Obuchowski NA, Bullen JA. Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys Med Biol. 2018;63(7):07TR01.
   PubMed Web of Science ®Google Scholar
• Vickers AJ, van Calster B, Steyerberg EW. A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res. 2019;3:18.
   PubMedGoogle Scholar
• Zeng J, Zeng J, Wu Q, et al. Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection. Ann Transl Med. 2020;8(17):1061.
   PubMed Web of Science ®Google Scholar
• Zhou C, Weng J, Liu C, et al. High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients. Am J Cancer Res. 2020;10(9):2768–2784.
   PubMed Web of Science ®Google Scholar
• Zhou T, Cai Z, Ma N, et al. A novel ten-gene signature predicting prognosis in hepatocellular carcinoma. Front Cell Dev Biol. 2020;8:629.
   PubMed Web of Science ®Google Scholar
• Li X, Huang H, Yu X, et al. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients. Surg Oncol. 2020;33:51–57.
   PubMed Web of Science ®Google Scholar
• Ho SY, Phua K, Wong L, et al. Extensions of the external validation for checking learned model interpretability and generalizability. Patterns. 2020;1(8):100129.
   PubMedGoogle Scholar
• Li Y, Ruan DY, Jia CC, et al. Surgical resection versus liver transplantation for hepatocellular carcinoma within the Hangzhou criteria: a preoperative nomogram-guided treatment strategy. Hepatobiliary Pancreat Dis Int. 2017;16(5):480–486.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Liu PH, Ho SY, et al. Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: a nomogram study. PLoS One. 2017;12(11):e0188031.
   PubMed Web of Science ®Google Scholar
• Huang K, Liao X, Han C, et al. Genetic variants and expression of cytochrome p450 oxidoreductase predict postoperative survival in patients with hepatitis B virus-related hepatocellular carcinoma. J Cancer. 2019;10(6):1453–1465.
   PubMed Web of Science ®Google Scholar
• Liu CY, Chen KF, Chen PJ. Treatment of liver cancer. Cold Spring Harb Perspect Med. 2015;5(9):a021535.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang R, Xu Z, et al. Advances in nanoliposomes for the diagnosis and treatment of liver cancer. Int J Nanomedicine. 2022;17:909–925.
   PubMed Web of Science ®Google Scholar
• Sheng R, Jin K, Sun W, et al. Prediction of therapeutic response of advanced hepatocellular carcinoma to combined targeted immunotherapy by MRI. Magn Reson Imaging. 2023;96:1–7.
   PubMed Web of Science ®Google Scholar
• Li W, Shen H, Han L, et al. A multiparametric fusion radiomics signature based on contrast-enhanced MRI for predicting early recurrence of hepatocellular carcinoma. J Oncol. 2022;2022:3704987.
   PubMed Web of Science ®Google Scholar
• Zhu HB, Zheng ZY, Zhao H, et al. Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma. Diagn Interv Radiol. 2020;26(5):411–419.
   PubMed Web of Science ®Google Scholar
• Jin Z, Wang M, Meng Y, et al. Prognostic implication of a cuproptosis-related miRNA signature in hepatocellular carcinoma. J Healthc Eng. 2022;2022:4694323.
   PubMed Web of Science ®Google Scholar
• Tao H, Wang C, Lu C, et al. Comprehensive analysis on the specific role and function of mitochondrial inner membrane protein MPV17 in liver hepatocellular carcinoma. Genet Res (Camb). 2022;2022:7236823.
   PubMed Web of Science ®Google Scholar
• Dai K, Liu C, Guan G, et al. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. BMC Cancer. 2022;22(1):496.
   PubMed Web of Science ®Google Scholar
• Zhou T, Wang T, Zeng K, et al. A nomogram based on a three pyroptosis gene model and clinical parameters for predicting prognosis of hepatocellular carcinoma. Gene. 2022;819:146243.
   PubMed Web of Science ®Google Scholar
• Li L, Xie R, Lu G. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Biosci Rep. 2021;41(6):BSR20210760.
   PubMed Web of Science ®Google Scholar
• Zeng H, Liu C, Zhou X, et al. A new prognostic strategy based on four DNA repair-associated lncRNAs for hepatocellular carcinoma. Comb Chem High Throughput Screen. 2022;25(5):906–918.
   PubMed Web of Science ®Google Scholar
• Li TE, Zhang Z, Wang Y, et al. A novel immunotype-based risk stratification model predicts postoperative prognosis and adjuvant TACE benefit in Chinese patients with hepatocellular carcinoma. J Cancer. 2021;12(10):2866–2876.
   PubMed Web of Science ®Google Scholar
• Wang H, Lu Y, Liu R, et al. A Non-invasive nomogram for preoperative prediction of microvascular invasion risk in hepatocellular carcinoma. Front Oncol. 2021;11:745085.
   PubMedGoogle Scholar
• Liu H, Yang M, Dong Z. HSPB11 is a prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma. Int J Gen Med. 2022;15:4017–4027.
   PubMed Web of Science ®Google Scholar
• Wang X, Gong Y, Deng T, et al. Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus-related hepatocellular carcinoma. J Cell Biochem. 2019;120(10):18246–18265.
   PubMed Web of Science ®Google Scholar
• Ji K, Zhu H, Wu W, et al. Tumor response and nomogram-based prognostic stratification for hepatocellular carcinoma after drug-eluting beads transarterial chemoembolization. J Hepatocell Carcinoma. 2022;9:537–551.
   PubMed Web of Science ®Google Scholar
• Yan H, Wang X, Zhou D, et al. Dynamic nomogram for predicting macrovascular invasion of patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. J Cancer. 2022;13(6):1914–1922.
   PubMed Web of Science ®Google Scholar
• Chen X, Lu Y, Shi X, et al. Development and validation of a novel model to predict regional lymph node metastasis in patients with hepatocellular carcinoma. Front Oncol. 2022;12:835957.
   PubMedGoogle Scholar
• Bai Y, Lian Y, Wu J, et al. A prognostic scoring system for predicting overall survival of patients with the TNM 8th edition stage I and II hepatocellular carcinoma after surgery: a population-based study. Cancer Manag Res. 2021;13:2131–2142.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li J, He T, et al. The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma. Cancer Sci. 2019;110(9):2905–2923.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ouyang Y, Huang Y, et al. Comprehensive bioinformatics analysis reveals potential lncRNA biomarkers for overall survival in patients with hepatocellular carcinoma: an on-line individual risk calculator based on TCGA cohort. Cancer Cell Int. 2019;19:174.
   PubMed Web of Science ®Google Scholar